Tirzepatide has emerged as a groundbreaking medication for type 2 diabetes, offering promising outcomes. However, the price of this innovative drug and its availability have become key issues for patients and healthcare providers. While tirzepatide has been authorized by regulatory agencies, its high-priced nature presents a significant challenge